Mepolizumab: Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in Greece
NCT04084613
·
clinicaltrials.gov ↗
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Severe Eosinophilic Asthma
Sponsor
Attikon Hospital